Home › Stocks › JSPR

Jasper Therapeutics, Inc. (JSPR): insider buying, hedge funds & Congress trades

Jasper Therapeutics, Inc. (JSPR): 4 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Sep 24, 2025Shizuru Judith Anne
Director
41,000$2.43$99.6Kno history
Sep 24, 2025Martell Ron
Director, Officer
41,000$2.43$99.6Kno history
Sep 24, 2025Lucas Svetlana
Director
20,000$2.43$48.6Kno history
Sep 24, 2025Wiggans Thomas G
Director
41,000$2.43$99.6Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for JSPR

Free account. Know when insiders, famous funds or Congress trade it.

Start free